SOM230
We provide customized and high-quality Pasireotide Diaspartate product for your project.
Pasireotide is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It is a somatostatin receptor (SSTR) agonist with selectively for SST1, SST2, SST3, and SST5 over SST4 (IC50s = 9.3,
CAS NO:54925-88-1
CAS NO:415684-38-7
CAS NO:40829-32-1
CAS NO:3788-44-1
CAS NO:2022956-42-7
CAS NO:
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View